GBI Research found that the Travel Vaccines market in the top seven markets was valued at $1,343m in 2012, increasing at a Compound Annual Growth Rate (CAGR) of 11% during the 2007-2012 historic period. The market is projected to witness growth of 7.5% during the 2012-2019 forecast period to reach $2,224m. The growth in the Travel Vaccines market is driven by increased uptake of hepatitis A vaccines, which is expected to grow at a CAGR of 7% during the forecast period and reach $423m in 2019 from $264m in 2012.
View full report with TOC:http://www.reportsandintelligence.com/travel-vaccines-to-2019-hepatitis-a-japanese-encephalitis-and-meningococcal-vaccine-segments-to-drive-growth-market
